サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1494770

神経修復と再生市場の2030年までの予測：製品タイプ、病態タイプ、用途、エンドユーザー、地域別の世界分析

Nerve Repair and Regeneration Market Forecasts to 2030 - Global Analysis By Product Type (Biomaterials, Neuromodulation Devices and Other Product Types), Condition Type, Application, End User and By Geography

出版日
ページ情報
英文 200+ Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
神経修復と再生市場の2030年までの予測：製品タイプ、病態タイプ、用途、エンドユーザー、地域別の世界分析
出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の神経修復と再生市場は2024年に103億米ドルを占め、予測期間中のCAGRは16.1％で成長し、2030年には253億米ドルに達する見込みです。

神経の修復と再生とは、体内の損傷または傷害を受けた神経を機能的な状態に回復させる自然または補助的なプロセスを指します。これには、損傷した神経組織の修復と神経線維の再生が含まれ、感覚と運動機能の回復を可能にします。このようなプロセスは、体内である程度自然に起こるが、手術や神経移植、再生療法の使用などの医療介入によって促進されることもあります。最終的な目標は、神経機能を回復させ、神経の損傷や障害からの回復を促進することです。

アルツハイマー病協会によると、2022年にはアメリカで65歳以上の650万人がアルツハイマー病を患っているといいます。

老年人口の増加

同市場が大きく成長しているのは、老人人口の増加が大きな要因です。ヘルスケアの進歩に伴い、神経関連疾患の治療を求める高齢者が増えています。この人口動態の変化が、神経の修復と再生に対応する革新的なソリューションへの需要を煽っています。高齢者が神経障害や神経損傷などの課題に直面する中、機能を回復させ、生活の質を向上させる治療法が急務となっています。この動向は、市場の拡大と革新の可能性を強調しています。

現在の治療法の有効性は限定的

現在の治療法の有効性が限られているため、市場は大きな課題に直面しています。進歩にもかかわらず、既存のアプローチの多くは、特に複雑な症例において、神経機能を完全に回復させるのに苦労しています。この限界は、再生の成果を向上させ、多様な患者のニーズに対応できる革新的なソリューションの差し迫った必要性を強調しています。成功率が高く、適用範囲が広い治療法の開拓は、市場が直面するハードルを克服する上で、依然として重要な目標です。

技術の進歩

神経修復と再生技術における最近の動向には、神経導管や足場などの生体工学的神経移植片の開発が含まれ、神経再生を促進しています。さらに、幹細胞治療、遺伝子治療、神経組織工学などの革新的アプローチが、神経修復の成果を高める可能性を示しています。高度な画像診断技術や神経刺激法も、神経経路のマッピングや神経再生の促進に役立っています。

高額な手技費用

この市場には高額な治療費がかかり、治療を求める患者にとって経済的な大きな障壁となっています。数万米ドルとは言わないまでも、数千ドルの出費となることが多く、利用しやすさが大きな懸念となります。このような高額な費用は、外科手術、専門的診断、術後ケアに及び、個人とヘルスケアシステムの経済的負担を増幅させています。この課題に対処することは、必要不可欠な神経修復と再生治療への公平なアクセスを確保するために極めて重要です。

COVID-19の影響：

COVID-19パンデミックは神経修復と再生市場に大きな影響を与え、ヘルスケア・サービスの中断と選択的手術の遅延を引き起こしました。患者の受診や外科手術の減少は市場成長の低下につながった。サプライチェーンの混乱も医療機器や治療の入手を妨げました。しかし、ヘルスケア・サービスが徐々に回復し、神経損傷に対する認識が高まるにつれて、市場は回復すると予想されます。遠隔医療と遠隔患者モニタリングの革新が市場力学を再構築し、神経修復と再生技術の今後の成長を促進するかもしれないです。

予測期間中、バイオマテリアル分野が最大となる見込み

予測期間中、生体材料が最大となる見込みです。これらのバイオマテリアルには、ハイドロゲル、足場、導管などが含まれ、損傷した神経の修復と再生促進のための有望なソリューションを提供します。市場の拡大は、神経損傷の発生件数の増加と低侵襲手術手技の採用増加によってさらに促進されます。さらに、現在進行中の研究努力や共同研究は、これらの生体材料の有効性とアクセシビリティの向上を目指しており、市場の継続的な成長を促進しています。

予測期間中、病院・診療所セグメントのCAGRが最も高くなると予測される

予測期間中、CAGRが最も高くなると予想されるのは病院・診療所分野です。これらの施設には高度な技術が備わっており、神経機能の回復と患者の生活の質の向上に重点を置く専門医療従事者が常駐しています。神経移植から神経刺激療法に至るまで、これらのセンターは個々のニーズに合わせた包括的なサービスを提供し、神経医学の進歩を促し、神経の損傷や症状を抱える人々の希望を育んでいます。

最大のシェアを占める地域

北米は、神経損傷・障害の有病率の増加、技術の進歩、革新的な治療オプションに対する需要の高まりなどを背景に、予測期間中最大の市場シェアを占めると予測されます。確立されたヘルスケア・インフラ、支援的な償還政策、高齢化人口の増加などの要因が市場拡大に寄与しています。主なプレーヤーは新規治療法の開発と製品ポートフォリオの拡充に注力しており、市場の成長をさらに後押ししています。

CAGRが最も高い地域：

アジア太平洋地域は、神経損傷の発生件数の増加、高齢者人口の増加、神経修復治療に対する意識の高まり、ヘルスケアインフラや技術の進歩など、いくつかの要因により、予測期間中に最も高いCAGRを維持すると予測されます。さらに、政府機関および民間機関の研究開発活動への投資が増加していることも、この地域における神経修復と再生技術の革新に拍車をかけています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレーヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査情報源
    • 1次調査情報源
    • 2次調査情報源
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の神経修復と再生市場：製品タイプ別

  • 生体材料
    • 神経導管
    • 神経保護剤
    • 神経包帯
    • 神経コネクター
  • 神経調節デバイス
    • 内部神経刺激装置
      • 脊髄刺激装置
      • 脳深部刺激装置
      • 仙骨神経刺激装置
      • 迷走神経刺激装置
    • 外部神経刺激装置
      • 経皮的電気神経刺激（TENS）
      • 経頭蓋磁気刺激（TMS）
      • 呼吸電気刺激装置
  • その他の製品タイプ

第6章 世界の神経修復と再生市場：病態タイプ別

  • 外傷性神経損傷
  • 神経変性疾患
  • 神経圧迫症候群
  • 末梢神経障害
  • その他の病態タイプ

第7章 世界の神経修復と再生市場：用途別

  • 神経移植
    • 自家移植
    • 同種移植
    • 異種移植
  • 幹細胞療法
    • 間葉系幹細胞（MSC）
    • 造血幹細胞（HSC）
    • 神経幹細胞（NSC）
  • 直接神経修復
    • 神経上膜修復
    • 神経周囲修復
    • グループ束修復
  • その他の用途

第8章 世界の神経修復と再生市場：エンドユーザー別

  • 病院と診療所
  • 外来手術センター（ASC）
  • 研究ラボおよび学術機関
  • その他のエンドユーザー

第9章 世界の神経修復と再生市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイリング

  • Medtronic, Plc.
  • Synovis Micro Companies Alliance
  • Axogen Corporation
  • Checkpoint Surgical
  • Synapse Biomedical Inc.
  • Polyganics
  • Boston scientific inc
  • Nuvectra Corporation
  • Abbott Laboratories
  • OrthoMed, Inc
  • NeuroSigma, Inc.
  • Stryker Corporation
  • Allergan plc
  • Baxter International Inc.
  • Collagen Matrix, Inc.
  • Integra LifeSciences Holdings Corporation
図表

List of Tables

  • Table 1 Global Nerve Repair and Regeneration Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Nerve Repair and Regeneration Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2022-2030) ($MN)
  • Table 4 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2022-2030) ($MN)
  • Table 5 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2022-2030) ($MN)
  • Table 6 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2022-2030) ($MN)
  • Table 7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2022-2030) ($MN)
  • Table 8 Global Nerve Repair and Regeneration Market Outlook, By Neuromodulation Devices (2022-2030) ($MN)
  • Table 9 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2022-2030) ($MN)
  • Table 10 Global Nerve Repair and Regeneration Market Outlook, By Spinal Cord Stimulators (2022-2030) ($MN)
  • Table 11 Global Nerve Repair and Regeneration Market Outlook, By Deep Brain Stimulators (2022-2030) ($MN)
  • Table 12 Global Nerve Repair and Regeneration Market Outlook, By Sacral Nerve Stimulators (2022-2030) ($MN)
  • Table 13 Global Nerve Repair and Regeneration Market Outlook, By Vagus Nerve Stimulators (2022-2030) ($MN)
  • Table 14 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2022-2030) ($MN)
  • Table 15 Global Nerve Repair and Regeneration Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2022-2030) ($MN)
  • Table 16 Global Nerve Repair and Regeneration Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2022-2030) ($MN)
  • Table 17 Global Nerve Repair and Regeneration Market Outlook, By Respiratory Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 18 Global Nerve Repair and Regeneration Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 19 Global Nerve Repair and Regeneration Market Outlook, By Condition Type (2022-2030) ($MN)
  • Table 20 Global Nerve Repair and Regeneration Market Outlook, By Traumatic Nerve Injuries (2022-2030) ($MN)
  • Table 21 Global Nerve Repair and Regeneration Market Outlook, By Neurodegenerative Diseases (2022-2030) ($MN)
  • Table 22 Global Nerve Repair and Regeneration Market Outlook, By Nerve Compression Syndromes (2022-2030) ($MN)
  • Table 23 Global Nerve Repair and Regeneration Market Outlook, By Peripheral Neuropathies (2022-2030) ($MN)
  • Table 24 Global Nerve Repair and Regeneration Market Outlook, By Other Condition Types (2022-2030) ($MN)
  • Table 25 Global Nerve Repair and Regeneration Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2022-2030) ($MN)
  • Table 27 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2022-2030) ($MN)
  • Table 28 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2022-2030) ($MN)
  • Table 29 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2022-2030) ($MN)
  • Table 30 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
  • Table 31 Global Nerve Repair and Regeneration Market Outlook, By Mesenchymal Stem Cells (MSCs) (2022-2030) ($MN)
  • Table 32 Global Nerve Repair and Regeneration Market Outlook, By Hematopoietic Stem Cells (HSCs) (2022-2030) ($MN)
  • Table 33 Global Nerve Repair and Regeneration Market Outlook, By Neural Stem Cells (NSCs) (2022-2030) ($MN)
  • Table 34 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair (2022-2030) ($MN)
  • Table 35 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2022-2030) ($MN)
  • Table 36 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2022-2030) ($MN)
  • Table 37 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2022-2030) ($MN)
  • Table 38 Global Nerve Repair and Regeneration Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 39 Global Nerve Repair and Regeneration Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 Global Nerve Repair and Regeneration Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 41 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 42 Global Nerve Repair and Regeneration Market Outlook, By Research Laboratories and Academic Institutes (2022-2030) ($MN)
  • Table 43 Global Nerve Repair and Regeneration Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC26285

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $10.3 billion in 2024 and is expected to reach $25.3 billion by 2030 growing at a CAGR of 16.1% during the forecast period. Nerve repair and regeneration refer to the natural or assisted processes by which damaged or injured nerves in the body are restored to their functional state. This involves the repair of damaged nerve tissue and the regeneration of nerve fibers, allowing for the restoration of sensory and motor functions. These processes can occur spontaneously to some extent in the body, but they can also be facilitated through medical interventions such as surgery, nerve grafting, or the use of regenerative therapies. The ultimate goal is to restore nerve function and facilitate recovery from nerve injuries or disorders.

According to the Alzheimer's Association, in 2022, 6.5 million people aged 65 or more in America were suffering from Alzheimer's disease.

Market Dynamics:

Driver:

Growing geriatric population

The market is experiencing significant growth, largely due to the increasing geriatric population. With advancements in healthcare, more elderly individuals are seeking treatments for nerve-related conditions. This demographic shift has fueled demand for innovative solutions catering to nerve repair and regeneration. As older adults face challenges such as neuropathy and nerve injuries, there's a pressing need for therapies that can restore function and improve quality of life. This trend underscores the market's potential for expansion and innovation.

Restraint:

Limited efficacy of current treatments

The market faces significant challenges due to the limited efficacy of current treatments. Despite advancements, many existing approaches struggle to fully restore nerve function, especially in complex cases. This limitation underscores the pressing need for innovative solutions that can enhance regeneration outcomes and address diverse patient needs. Developing therapies with higher success rates and broader applicability remains a critical goal in overcoming the hurdles faced by the market.

Opportunity:

Technological advancements

Recent advancements in nerve repair and regeneration technology include the development of bioengineered nerve grafts, such as nerve conduits and scaffolds, to promote nerve regeneration. Additionally, innovative approaches like stem cell therapy, gene therapy, and nerve tissue engineering have shown promise in enhancing nerve repair outcomes. Advanced imaging techniques and neurostimulation methods also aid in mapping nerve pathways and facilitating nerve regeneration.

Threat:

High cost of procedures

The market is marked by steep procedure costs, posing significant financial barriers for patients seeking treatment. With expenses often ranging in the thousands, if not tens of thousands, of dollars, accessibility becomes a major concern. These high costs encompass surgical procedures, specialized diagnostics, and post-operative care, amplifying the financial strain on individuals and healthcare systems alike. Addressing this challenge is crucial for ensuring equitable access to essential nerve repair and regeneration therapies.

Covid-19 Impact:

The COVID-19 pandemic significantly affected the Nerve Repair and Regeneration market, causing disruptions in healthcare services and delaying elective procedures. Reduced patient visits and surgical interventions led to a decline in market growth. Supply chain disruptions also hampered the availability of medical devices and treatments. However, with the gradual recovery of healthcare services and increased awareness of nerve injuries, the market is expected to rebound. Innovations in telemedicine and remote patient monitoring might reshape the market dynamics, driving future growth in nerve repair and regeneration technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials is expected to be the largest during the forecast period. These biomaterials include hydrogels, scaffolds, and conduits, offer promising solutions for repairing damaged nerves and promoting regeneration. The market's expansion is further propelled by rising incidences of nerve injuries, coupled with the increasing adoption of minimally invasive surgical techniques. Additionally, ongoing research efforts and collaborations aim to enhance the efficacy and accessibility of these biomaterials, fostering continued market growth.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities are equipped with advanced technologies and staffed by expert medical professionals who focus on restoring nerve function and improving patients' quality of life. From nerve grafting to nerve stimulation therapies, these centers offer comprehensive services tailored to individual needs, driving advancements in neurological medicine and fostering hope for those with nerve injuries or conditions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing prevalence of nerve injuries and disorders, technological advancements, and rising demand for innovative treatment options. Factors such as a well-established healthcare infrastructure, supportive reimbursement policies, and a growing aging population contribute to market expansion. Key players are focusing on developing novel therapies and expanding their product portfolios, further fueling market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to several factors such as increasing incidences of nerve injuries, growing geriatric population, rising awareness about nerve repair treatments, and advancements in healthcare infrastructure and technologies. Additionally, the increasing investments in research and development activities by both government and private organizations are fueling innovation in nerve repair and regeneration technologies in the region.

Key players in the market

Some of the key players in Nerve Repair and Regeneration market include Medtronic, Plc., Synovis Micro Companies Alliance, Axogen Corporation, Checkpoint Surgical, Synapse Biomedical Inc., Polyganics, Boston scientific inc, Nuvectra Corporation, Abbott Laboratories, OrthoMed, Inc NeuroSigma, Inc., Stryker Corporation, Allergan plc, Baxter International Inc., Collagen Matrix, Inc. and Integra LifeSciences Holdings Corporation

Key Developments:

In March 2024, Medtronic announced the launch of the new UNiD(TM) ePRO service in the United States. This solution will change the way patient outcomes are collected for spine surgeons, reducing the burden on clinic staff and patients. Medtronic has partnered with OBERD, a leading practice intelligence data collection company, to provide spine surgeons with an electronic Patient Reported Outcomes (ePRO) system.

In November 2023, Medtronic launched a new frontier in treating high blood pressure. The U.S. Food and Drug Administration (FDA) today approved the Medtronic Symplicity Spyral(TM) renal denervation system for use in the United States. The system, which carries the FDA's Breakthrough Device designation, uses radio frequency to disrupt overactive nerves in the kidneys and help lower blood pressure.

Product Types Covered:

  • Biomaterials
  • Neuromodulation Devices
  • Other Product Types

Condition Types Covered:

  • Traumatic Nerve Injuries
  • Neurodegenerative Diseases
  • Nerve Compression Syndromes
  • Peripheral Neuropathies
  • Other Condition Types

Applications Covered:

  • Nerve Grafting
  • Stem Cell Therapy
  • Direct Nerve Repair
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Research Laboratories and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product Type

  • 5.1 Introduction
  • 5.2 Biomaterials
    • 5.2.1 Nerve Conduits
    • 5.2.2 Nerve Protectors
    • 5.2.3 Nerve Wraps
    • 5.2.4 Nerve Connectors
  • 5.3 Neuromodulation Devices
    • 5.3.1 Internal Neurostimulation Devices
      • 5.3.1.1 Spinal Cord Stimulators
      • 5.3.1.2 Deep Brain Stimulators
      • 5.3.1.3 Sacral Nerve Stimulators
      • 5.3.1.4 Vagus Nerve Stimulators
    • 5.3.2 External Neurostimulation Devices
      • 5.3.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 5.3.2.2 Transcranial Magnetic Stimulation (TMS)
      • 5.3.2.3 Respiratory Electrical Stimulation Devices
  • 5.4 Other Product Types

6 Global Nerve Repair and Regeneration Market, By Condition Type

  • 6.1 Introduction
  • 6.2 Traumatic Nerve Injuries
  • 6.3 Neurodegenerative Diseases
  • 6.4 Nerve Compression Syndromes
  • 6.5 Peripheral Neuropathies
  • 6.6 Other Condition Types

7 Global Nerve Repair and Regeneration Market, By Application

  • 7.1 Introduction
  • 7.2 Nerve Grafting
    • 7.2.1 Autografts
    • 7.2.2 Allografts
    • 7.2.3 Xenografts
  • 7.3 Stem Cell Therapy
    • 7.3.1 Mesenchymal Stem Cells (MSCs)
    • 7.3.2 Hematopoietic Stem Cells (HSCs)
    • 7.3.3 Neural Stem Cells (NSCs)
  • 7.4 Direct Nerve Repair
    • 7.4.1 Epineural Repair
    • 7.4.2 Perineural Repair
    • 7.4.3 Group Fascicular Repair
  • 7.5 Other Applications

8 Global Nerve Repair and Regeneration Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Research Laboratories and Academic Institutes
  • 8.5 Other End Users

9 Global Nerve Repair and Regeneration Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic, Plc.
  • 11.2 Synovis Micro Companies Alliance
  • 11.3 Axogen Corporation
  • 11.4 Checkpoint Surgical
  • 11.5 Synapse Biomedical Inc.
  • 11.6 Polyganics
  • 11.7 Boston scientific inc
  • 11.8 Nuvectra Corporation
  • 11.9 Abbott Laboratories
  • 11.10 OrthoMed, Inc
  • 11.11 NeuroSigma, Inc.
  • 11.12 Stryker Corporation
  • 11.13 Allergan plc
  • 11.14 Baxter International Inc.
  • 11.15 Collagen Matrix, Inc.
  • 11.16 Integra LifeSciences Holdings Corporation